by persistent airflow limitation, a condition characterized by persistent airflow limitation. A major site of airflow limitation in COPD is the small conducting airways. Small Airway Obstruction is a harbinger of COPD and abnormalities in the small airways in smokers may or may not have COPD. Thus the aim of the study is early detection of small airway obstruction and determine the Correlation of Forced Expiratory Flow (FEF) 25-75% and the number of pack-years among smokers.
was done.
Results: There was significant correlation of FEF 25-75 and smoking pack-years with inverse relationship (r = −0.35, P = 0.0014). The smoking pack-years cut-off value that will give low FEF25-75 was 16.5 smoking pack-years.
Conclusion: FEF25-75 may be use for early detection of small airway obstruction. This may help encourage smokers to quit earlier before significant airway obstruction symptomatology occurs and prevent further progression to COPD and other complications of smoking. Methods: Sixty-seven patients (age 5-55 years) with moderatesevere Dermatophagoides pteronyssinus (Der-p) and Dermatophagoides farinae (Der-f ) allergic rhinitis and/or asthma were randomized (2:2:1) into SLIT (n = 27), SCIT (n = 26) and medication (n = 14) groups. Rhinitis and asthma symptom and medication scores, visual analogue score (VAS), serum Der-p specific IgG4 (Der-p-sIgG4), CD4+CD25+FoxP3+ regulatory T cells (CD4+CD25+FoxP3+ Tregs) and serum cytokines were measured.
Results: After 1-year treatment, a significant improvement of total rhinitis score (TRS), total rhinitis medication score (TRMS) and VAS occurred in both SLIT and SCIT, and total rhinitis symptom score (TRSS) was improved in SCIT (P < 0.05) compared with the medication group. CD4+CD25+FoxP3+ Tregs had a trend toward up-regulation in SLIT and inversely correlated with total rhinitis medication score (P = 0.014) and total rhinitis score (P = 0.024). Der-p-sIgG4 significantly increased in SLIT and SCIT (P < 0.05), and was 30 times higher in SCIT than SLIT after the 1-year treatment (P < 0.05). Serum INF-γ significantly increased in SCIT after 1 year treatment (P = 0.011) and had correlated with clinical improvement. bilitation Working Group (PRWG) was involved in a SWOT (Strengths, Weaknesses, Opportunities, Threats) analysis of the current pulmonary rehabilitation (PR) service. Two of the key areas identified for review were programme delivery and education. The Working Group members believed they were doing a good job based on the objective outcome measures used, but the experiences and expectations of participants had not been explored thoroughly.
Conclusion

Methods: In September 2013 a Pulmonary Rehabilitation Consumer
Focus Group was established. The group was formed from members of the different community exercise groups that support PR. In 2016, the consumer representatives and clinicians decided to try the consumer-led coffee and exercise support group model. This group would ensure all aspects (physical, social, psychological and spiritual) of one's wellbeing are cared for. The group includes 30 min, a light exercise session led by expert patient volunteers and a chat session afterwards to allow the attendees to voice their health concerns, share stories and coping strategies.
Results: Consumers have established four support groups in the Canterbury region: Rangiora, Shirley, Aranui and Templeton. Currently, these four groups are supporting more than 50 people living with chronic respiratory illnesses over a cup of coffee.
Conclusion:
The consumer-led support groups have achieved multiple benefits to the participants and the health sector.
• These groups are independent and do not depend on external resources; this ensures their sustainability.
Respirology ( 
